Physician profile
Jimmy Pan
NPI 1770110512
$1,212.89
in general payments reported to CMS, 2019-2025
14 companies · $634 in 2025
The $634 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $25.53 · 2024: $554 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.35 | 2024-2025 | |
| Novo Nordisk INC | $235.93 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Ucb, INC. | $141.04 | 2024-2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.19 | 2023-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $114.88 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $91.49 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $74.00 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $59.95 | 2024-2025 | Otezla, Otezla, Repatha |
| Inspire Medical Systems, INC. | $23.30 | 2025 | Inspire |
| Axsome Therapeutics, INC. | $17.97 | 2024 | Auvelity |
| Dexcom, INC. | $17.33 | 2024 | Dexcom G6 Transmitter |
| Eisai INC. | $16.80 | 2024 | |
| Pfizer INC. | $15.71 | 2024 | |
| Alexion Pharmaceuticals, INC. | $13.95 | 2025 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.